# Commission Implementing Regulation (EU) No 1056/2013 of 29 October 2013 amending the Annex to Regulation (EU) No 37/2010 on pharmacologically active substances and their classification regarding maximum residue limits in foodstuffs of animal origin, as regards the substance neomycin (Text with EEA relevance), Annex

Extent: E+W+S+N.I.

In Table 1 of the Annex to Regulation (EU) No 37/2010, the entry for the substance neomycin is replaced by the following:
Pharmacologically active substance
Marker residue
Animal Species
MRL
Target Tissues
Other provisions (according to Article 14(7) of Regulation (EC) No 470/2009)
Therapeutic Classification
‘Neomycin (including framycetin)
Neomycin B
All food producing species
500 μg/kg
Muscle
For fin fish the muscle MRL relates to “muscle and skin in natural proportions”.
MRLs for fat, liver and kidney do not apply to fin fish.
For porcine and poultry species the fat MRL relates to “skin and fat in natural proportions”
Anti-infectious agents/Antibiotics’
500 μg/kg
Fat
5 500 μg/kg
Liver
9 000 μg/kg
Kidney
1 500 μg/kg
Milk
500 μg/kg
Eggs

---
Source: https://www.legislation.gov.uk/eur/2013/1056/annex (the official version)
Page: https://openlegislation.uk/eu-regulation-2013-1056/annex
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.